| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
Search
|
|
| |
Antibody Deal-Making & Financing | |
| |
November 26, 2002 |
Biochemistry / Immunology |
|
| |
|
|
| |
Strategic Research Institute, U.S. Grant- A Wyndham Historic Hotel
February 27 - 28, 2003
ORGANIZED INTO FOUR SECTIONS: 1- Buy & Sell Side Views
2 - Pharma & Biotech Antibody Dealmaking & Partnering Showcase
3 - Intellectual Property Forum
4 - Early Stage & Private Antibody Companies: The Future of Dealmaking
|
|
|
|
|
|
|
|
Organized by:
|
|
Ed Drilon |
|
|
Invited Speakers:
|
|
FEATURING: Abgenix
Amgen
Baxter Bioscience
Bayer
Biosite Inc.
Bioscience Ventures Inc.
Bioforesight Strategies
Cambridge Antibody Technology
Dyax Corporation
Finnegan & Henderson
Genentech
Genway Biotech
IDEC Pharmaceuticals
Protherics PLC
Raven Biotechnologies
RBC Capital Partners
Sangstat Medical Corporation
Shire - Biologics Division
Signet Laboratories
Six Degrees Capital
Synergy Capital Partners
Titan International Partners
Vaccinex
Viventia Biotech
Xerion Pharmaceuticals
XOMA
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
tbd
|
|
|
|
|
|
|
|
Registration:
|
|
888-666-8514
|
|
|
E-mail:
|
|
edrilon@srinstitute.com
|
|
|
|
|
|
|
| |
Posted by:
|
|
Jennifer Law
|
|
|
Host:
|
|
12.3.58.15
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|